Treatment of arrhythmias: basic considerations.
D000200:Action Potentials; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001949:Bretylium Compounds / Q000494:pharmacology / Q000627:therapeutic use; D004594:Electrophysiology; D006329:Heart Conduction System / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008012:Lidocaine / Q000494:pharmacology / Q000627:therapeutic use; D008564:Membrane Potentials; D010672:Phenytoin / Q000494:pharmacology / Q000627:therapeutic use; D011342:Procainamide / Q000494:pharmacology / Q000627:therapeutic use; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use; D011802:Quinidine / Q000494:pharmacology / Q000627:therapeutic use
D001949:Bretylium Compounds; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide